1. Home
  2. SBFM vs AZTR Comparison

SBFM vs AZTR Comparison

Compare SBFM & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.13

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.18

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
AZTR
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.5M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
SBFM
AZTR
Price
$1.13
$0.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$4.00
AVG Volume (30 Days)
598.2K
1.2M
Earning Date
04-03-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.06
EPS
N/A
N/A
Revenue
$36,305,891.00
N/A
Revenue This Year
$40.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.11
N/A
52 Week Low
$0.25
$0.10
52 Week High
$3.05
$1.09

Technical Indicators

Market Signals
Indicator
SBFM
AZTR
Relative Strength Index (RSI) 38.45 64.52
Support Level $1.09 $0.17
Resistance Level $1.29 $0.23
Average True Range (ATR) 0.10 0.01
MACD 0.02 0.00
Stochastic Oscillator 36.67 84.04

Price Performance

Historical Comparison
SBFM
AZTR

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: